Clinic
San Joaquin Valley Health Group INC
San Joaquin Valley Health Group INC was paid $6.49M by Medicaid between Jan 2018 and Dec 2024, across 31 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 61% of everything it billed.
33Billing provider infoSAN JOAQUIN VALLEY HEALTH GROUP INC
BAKERSFIELD, CA 93311
BAKERSFIELD, CA 93311
33aNPI1639603897assigned 04/14/2017
33bProvider typeUrgent Care Clinic/Center
28Total paid$6.49M
24GClaims142,644
24DCodes billed31
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in California
Rank by total paid#27 of 284
Median peer was paid$147K
This provider vs. median44×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,688 | $603K | |
| 2019 | 33,144 | $1.01M | |
| 2020 | 24,802 | $742K | |
| 2021 | 24,681 | $956K | |
| 2022 | 20,592 | $1.10M | |
| 2023 | 13,576 | $969K | |
| 2024incomplete | 12,161 | $1.11M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 61% | 45,908 | 41,226 | $3.98M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 21% | 14,392 | 14,217 | $1.34M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 11,457 | 10,916 | $929K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.1% | 2,501 | 2,490 | $204K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 207 | 193 | $14K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,640 | 1,567 | $4K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 42 | 42 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 6,756 | 5,129 | $2K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 19 | 19 | $2K |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | <1% | 34,922 | 30,861 | $2K |
| 99051 | <1% | 11,561 | 10,406 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 4,527 | 3,100 | $1K |
19 more codes
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,234 | $890.86 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 322 | $480.55 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 594 | $452.78 |
| 81003 | <1% | 2,670 | $404.02 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 453 | $203.99 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,042 | $181.20 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 29 | $153.93 |
| 93000 | <1% | 58 | $139.09 | |
| 72100 | <1% | 12 | $32.35 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 291 | $5.56 |
| 99000 | 0% | 196 | $0.00 | |
| A9150 | Non-prescription drugs | 0% | 110 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 175 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 208 | $0.00 |
| 99441 | 0% | 36 | $0.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 53 | $0.00 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 55 | $0.00 |
| 81025 | 0% | 127 | $0.00 | |
| 99442 | 0% | 47 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKANG, YADWINDER (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Transamerica Medical Group INC. | Tulare, CA | $1.52M |
| San Joaquin Valley Health Group INC | Bakersfield, CA | $551K |
| Transamerica Medical Group INC. | Delano, CA | $404K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.